Abcam PLC
LSE:ABC
Abcam PLC
Accounts Payable
Abcam PLC
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcam PLC
LSE:ABC
|
Accounts Payable
£56.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Accounts Payable
$11.8m
|
CAGR 3-Years
128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Accounts Payable
$103k
|
CAGR 3-Years
-64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Accounts Payable
$7.1m
|
CAGR 3-Years
92%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Accounts Payable
£17.8m
|
CAGR 3-Years
45%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Accounts Payable
£34.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-4%
|
See Also
What is Abcam PLC's Accounts Payable?
Accounts Payable
56.7m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Accounts Payable amounts to 56.7m GBP.
What is Abcam PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
18%
Over the last year, the Accounts Payable growth was -1%. The average annual Accounts Payable growth rates for Abcam PLC have been 11% over the past three years , 14% over the past five years , and 18% over the past ten years .